- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14.10. | BAYZED HEALTH (02609): CHANGE OF JOINT COMPANY SECRETARY, AUTHORISED REPRESENTATIVE AND PROCESS AGENT; AND WAIVER FROM STRICT COMPLIANCE WITH RULES 3.28 ... | - | HKEx | ||
| 26.09. | BAYZED HEALTH (02609): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | 2 | HKEx | ||
| BAYZED HEALTH GROUP Aktie jetzt für 0€ handeln | |||||
| 26.09. | BAYZED HEALTH (02609): APPOINTMENT OF SENIOR MANAGEMENT, CHANGE OF COMPOSITION OF THE BOARD COMMITTEES AND CHANGE OF DIRECTOR | 4 | HKEx | ||
| 26.09. | BAYZED HEALTH (02609): 2025 INTERIM REPORT | - | HKEx | ||
| 19.09. | BAYZED HEALTH (02609): NEW ARRANGEMENTS ON DISSEMINATION OF CORPORATE COMMUNICATIONS TO NON-REGISTERED SHAREHOLDERS | - | HKEx | ||
| 19.09. | BAYZED HEALTH (02609): NEW ARRANGEMENTS ON DISSEMINATION OF CORPORATE COMMUNICATIONS TO REGISTERED SHAREHOLDERS | - | HKEx | ||
| 26.08. | BAYZED HEALTH (02609): ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2025 | 1 | HKEx | ||
| 22.08. | BAYZED HEALTH (02609): VOLUNTARY ANNOUNCEMENT INCLUSION OF THE COMPANY AS A CONSTITUENT OF THE HANG SENG INDEX SERIES | 1 | HKEx | ||
| 13.08. | BAYZED HEALTH (02609): DATE OF BOARD MEETING | 3 | HKEx | ||
| 26.06. | BAYZED HEALTH (02609): VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE | - | HKEx | ||
| 23.06. | BRIEF: Bayzed Health jumps in Hong Kong trading debut | 1 | Bamboo Works | ||
| 20.06. | BAYZED HEALTH (02609): ANNOUNCEMENT OF FINAL OFFER PRICE AND ALLOTMENT RESULTS | 1 | HKEx | ||
| 20.06. | BAYZED HEALTH (02609): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | 5 | HKEx | ||
| 20.06. | BAYZED HEALTH (02609): TERMS OF REFERENCE FOR NOMINATION COMMITTEE UNDER THE BOARD OF DIRECTOR | 1 | HKEx | ||
| 20.06. | BAYZED HEALTH (02609): TERMS OF REFERENCE FOR REMUNERATION COMMITTEE UNDER THE BOARD OF DIRECTORS | 1 | HKEx | ||
| 20.06. | BAYZED HEALTH (02609): TERMS OF REFERENCE FOR AUDIT COMMITTEE UNDER THE BOARD OF DIRECTORS | 1 | HKEx | ||
| 20.06. | BAYZED HEALTH (02609): SECOND AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION | 1 | HKEx | ||
| 18.06. | GREEN ECONOMY (01315): DISCLOSEABLE TRANSACTION - INVESTMENT IN BAYZED HEALTH | - | HKEx | ||
| 13.06. | BRIEF: Bayzed Health to raise up to $115 million in Hong Kong IPO | 1 | Bamboo Works | ||
| 13.06. | BAYZED HEALTH (02609): GLOBAL OFFERING | 1 | HKEx |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 49,510 | -1,02 % | DEUTSCHE BANK RESEARCH stuft Fresenius SE auf 'Buy' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat das Kursziel für Fresenius von 52 auf 53 Euro angehoben und die Einstufung auf "Buy" belassen. Die anstehenden Quartalszahlen des Medizinkonzerns... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 48,740 | +0,35 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 16,870 | 0,00 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 46,430 | -0,28 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 33,040 | 0,00 % | BrightSpring Health Services GAAP EPS of $0.17 misses by $0.15, revenue of $3.33B misses by $20M | ||
| GERRESHEIMER | 27,340 | -0,94 % | Gerresheimer: Weitere Details - millionenschwere Fehlbuchung | Am Wochenende hat der Spezialverpackungshersteller Gerresheimer per Ad-Hoc-Mitteilung dem Kapitalmarkt weitere Details zur laufenden Prüfung problematischer Buchungen im Konzernbericht für das Fiskaljahr... ► Artikel lesen | |
| UNITEDHEALTH | 296,00 | +0,61 % | Earnings Preview - Teil 1: Make or Break für den Markt: Die Zahlen von UnitedHealth, Microsoft & Alphabet! | © Foto: Richard Drew/AP/dpaDiese in den kommenden Tagen (KW44) anstehenden US-Quartalszahlen müssen Anlegerinnen und Anleger kennen: Herausforderungen, Erwartungen und die aktuell eingepreisten Kursreaktionen... ► Artikel lesen | |
| GENEDX | 137,17 | +4,20 % | GeneDx raises 2025 revenue guidance to $428M amid accelerating exome and genome test growth | ||
| BUTTERFLY NETWORK | 2,695 | 0,00 % | Butterfly Network reaffirms $91M-$95M 2025 revenue target while accelerating AI and chip innovation | ||
| PROCEPT BIOROBOTICS | 34,040 | 0,00 % | PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance | SAN JOSE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 44,060 | +0,36 % | JPMORGAN stuft CARL ZEISS MEDITEC AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Carl Zeiss Meditec mit einem Kursziel von 35,10 Euro auf "Underweight" belassen. Vor den am 11. Dezember anstehenden Quartalszahlen lägen seine... ► Artikel lesen | |
| BETA BIONICS | 27,210 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| PROGYNY | 18,690 | 0,00 % | Progyny, Inc.: Progyny Expands Global Benefits to Include Pregnancy, Postpartum, and Menopause | Global employers can now empower their workforces with comprehensive women's health benefits, supported by localized expertiseNEW YORK, Oct. 22, 2025. (Nasdaq: PGNY), a global leader in women's health... ► Artikel lesen | |
| CLEARPOINT NEURO | 23,230 | 0,00 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles | SOLANA BEACH, CALIFORNIA / ACCESS Newswire / October 7, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 24,280 | 0,00 % | Privia Health Group, Inc. - 8-K, Current Report |
BAYZED HEALTH GROUP INC gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BAYZED HEALTH GROUP INC finden Sie auf Wallstreet Online.